Phase-3 trial of Covaxin begins in Odisha institute
The third phase human trial of Covaxin, the much-awaited indigenously developed Covid-19 vaccine, has begun at an institute here, a senior official said on Friday.
Full Article
Phase-3 trial of Covaxin begins in Odisha institute
IndiaTimes
0 shares
1 views
You might like
Related news coverage
Bharat Biotech's COVID-19 vaccine 'Covaxin' commences phase-3 trial at AIIMS
Mid-Day
The Phase-III human trials of indigenous Covid-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New..